Oral Misoprostol Cuts Cesarean Risk Versus Vaginal Dinoprostone
This meta-analysis clarifies a route-specific trade-off: oral misoprostol lowers cesarean birth while vaginal dinoprostone shortens time to delivery, with comparable safety.
📅 Journal publication: Aug 2026·Last updated: Aug 5, 2026
Oral misoprostol reduces cesarean rates compared to vaginal dinoprostone.
Labor induction is a common procedure, and understanding the optimal pharmacologic agents can improve maternal and neonatal outcomes. Oral misoprostol reduced cesarean birth rates (relative risk (RR) 0.83) and oxytocin augmentation (RR 0.89) compared to vaginal dinoprostone, which resulted in more vaginal births within 24 hours (RR 0.91) and a shorter induction-to-birth interval. Both medications showed comparable safety profiles, making oral misoprostol a viable option for selected patients, though clinical settings and population differences should be considered. Oral misoprostol may lower cesarean rates, while vaginal dinoprostone accelerates labor within 24 hours.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Yeretsian T, Mogharbel H, Rozzah R, Ashraf R, Kirubarajan A, Thorlund K, D'Souza R
Citation:Yeretsian T, Mogharbel H, Rozzah R, et al. Oral Misoprostol Versus Vaginal Dinoprostone for Labor Induction: A Systematic Review and Meta-Analysis. The journal of obstetrics and gynaecology research. 2026;52(8):e70369. doi:10.1111/jog.70369